norovirus GII.4 Sydney
Selected indexed studies
- Emergence of GII.4 Sydney[P16]-like Norovirus-Associated Gastroenteritis, China, 2020-2022. (Emerg Infect Dis, 2023) [PMID:37610173]
- Global prevalence of norovirus gastroenteritis after emergence of the GII.4 Sydney 2012 variant: a systematic review and meta-analysis. (Front Public Health, 2024) [PMID:38993708]
- Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017-2018. (Emerg Infect Dis, 2019) [PMID:31310212]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Emergence of GII.4 Sydney[P16]-like Norovirus-Associated Gastroenteritis, China, 2020-2022. (2023) pubmed
- Global prevalence of norovirus gastroenteritis after emergence of the GII.4 Sydney 2012 variant: a systematic review and meta-analysis. (2024) pubmed
- Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017-2018. (2019) pubmed
- Norovirus: An Overview of Virology and Preventative Measures. (2022) pubmed
- High prevalence of norovirus GII.4 Sydney among children with acute gastroenteritis in Bangladesh, 2018-2021. (2023) pubmed
- Functional diversity in GII.4 norovirus entry: HBGA binding and capsid clustering dynamics. (2025) pubmed
- Molecular Evolution and Epidemiology of Norovirus GII.4 Viruses in the United States. (2025) pubmed
- Functional Diversity in GII.4 Norovirus Entry: HBGA Binding and Capsid Clustering Dynamics. (2025) pubmed
- Molecular Evolution of GII.P31/GII.4_Sydney_2012 Norovirus over a Decade in a Clinic in Japan. (2024) pubmed
- Emerging norovirus GII.4 Sydney[P31] causing acute gastroenteritis outbreak in children in Japan, during COVID-19, 2021. (2022) pubmed